-The United Nations The United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) has announced its involvement in an international partnership to improve civil registration and vital statistics (CRVS) systems in the Asia-Pacific region. Shun-ichi Murata, ESCAP Deputy Executive Secretary, hailed the partnership, announced in New York yesterday at an event that included former United States Secretary of State Hillary Clinton and the city's former Mayor, Michael Bloomberg, who...

-The Hindu Business Line   Suicide is principally a mental health issue. This is why we must welcome its decriminalisation Our lawmakers need to be congratulated for setting aside their differences and acting in concert to remove one of the big colonial era blots on our statute books - Section 309 of the Indian Penal Code, which treated attempted suicide as a crime. Since law and order is a State subject, a mere...

-The Indian Express The World Universal Health Coverage Day, observed on December 12, builds on growing global momentum towards introducing universal health coverage (UHC) in national health plans and reinforces the case for including UHC as a prominent sustainable development goal to be adopted by the UN next year. India proposes to implement a programme of national health assurance, which embraces the principles of UHC. It is expected that the government...

-Livemint The development economist on the Modi government's initiatives and his stand on them, and MGNREGS The Narendra Modi-led government should consider replacing inefficient subsidies with a basic monthly income for all citizens, says Pranab Bardhan , emeritus professor of economics at the University of California at Berkeley. Bardhan, who recently sparred with economists Jagdish Bhagwati and Arvind Panagariya in a debate over the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS),...

-The Hindu In a significant development for the pharmaceutical industry, the Supreme Court has rejected multinational Bayer's appeal to block production and sales of the low cost version of its kidney cancer drug, sorafenib tosylate (branded as Nexavar), by Natco Pharmaceuticals. Hyderabad-based Natco was granted the first and to date only compulsory licence (CL) by the government in 2012 to make and sell a patented drug at a fraction of the...